Synthesis and in vitro investigation of halogenated 1, 3‐bis(4‐nitrophenyl)triazenide salts as antitubercular compounds. (14th September 2017)
- Record Type:
- Journal Article
- Title:
- Synthesis and in vitro investigation of halogenated 1, 3‐bis(4‐nitrophenyl)triazenide salts as antitubercular compounds. (14th September 2017)
- Main Title:
- Synthesis and in vitro investigation of halogenated 1, 3‐bis(4‐nitrophenyl)triazenide salts as antitubercular compounds
- Authors:
- Torfs, Eveline
Vajs, Jure
de Macedo, Maíra Bidart
Cools, Freya
Vanhoutte, Bieke
Gorbanev, Yury
Bogaerts, Annemie
Verschaeve, Luc
Caljon, Guy
Maes, Louis
Delputte, Peter
Cos, Paul
Košmrlj, Janez
Cappoen, Davie - Abstract:
- Abstract : The diverse pharmacological properties of the diaryltriazenes have sparked the interest to investigate their potential to be repurposed as antitubercular drug candidates. In an attempt to improve the antitubercular activity of a previously constructed diaryltriazene library, eight new halogenated nitroaromatic triazenides were synthesized and underwent biological evaluation. The potency of the series was confirmed against the Mycobacterium tuberculosis lab strain H37Ra, and for the most potent derivative, we observed a minimal inhibitory concentration of 0.85 μm . The potency of the triazenide derivatives against M. tuberculosis H37Ra was found to be highly dependent on the nature of the halogenated phenyl substituent and less dependent on cationic species used for the preparation of the salts. Although the inhibitory concentration against J774A.1 macrophages was observed at 3.08 μm, the cellular toxicity was not mediated by the generation of nitroxide intermediate as confirmed by electron paramagnetic resonance spectroscopy, whereas no in vitro mutagenicity could be observed for the new halogenated nitroaromatic triazenides when a trifluoromethyl substituent was present on both the aryl moieties. Abstract : Halogenated 1, 3‐Bis(4‐Nitrophenyl)triazenide salts were synthesized and tested in vitro against Mycobacterium tuberculosis . The compounds showed selective activity towards Mycobacterium tuberculosis and Staphylococcus aureus but were unable to inhibit theAbstract : The diverse pharmacological properties of the diaryltriazenes have sparked the interest to investigate their potential to be repurposed as antitubercular drug candidates. In an attempt to improve the antitubercular activity of a previously constructed diaryltriazene library, eight new halogenated nitroaromatic triazenides were synthesized and underwent biological evaluation. The potency of the series was confirmed against the Mycobacterium tuberculosis lab strain H37Ra, and for the most potent derivative, we observed a minimal inhibitory concentration of 0.85 μm . The potency of the triazenide derivatives against M. tuberculosis H37Ra was found to be highly dependent on the nature of the halogenated phenyl substituent and less dependent on cationic species used for the preparation of the salts. Although the inhibitory concentration against J774A.1 macrophages was observed at 3.08 μm, the cellular toxicity was not mediated by the generation of nitroxide intermediate as confirmed by electron paramagnetic resonance spectroscopy, whereas no in vitro mutagenicity could be observed for the new halogenated nitroaromatic triazenides when a trifluoromethyl substituent was present on both the aryl moieties. Abstract : Halogenated 1, 3‐Bis(4‐Nitrophenyl)triazenide salts were synthesized and tested in vitro against Mycobacterium tuberculosis . The compounds showed selective activity towards Mycobacterium tuberculosis and Staphylococcus aureus but were unable to inhibit the growth of Escherichia coli, Salmonella typhimurium, Pseudomonas aeruginosa and Candida albicans . The trifluoromethyl substituent proved crucial to prevent the metabolization of the compounds into gentoxic metabolites in vitro. … (more)
- Is Part Of:
- Chemical biology & drug design. Volume 91:Number 2(2018)
- Journal:
- Chemical biology & drug design
- Issue:
- Volume 91:Number 2(2018)
- Issue Display:
- Volume 91, Issue 2 (2018)
- Year:
- 2018
- Volume:
- 91
- Issue:
- 2
- Issue Sort Value:
- 2018-0091-0002-0000
- Page Start:
- 631
- Page End:
- 640
- Publication Date:
- 2017-09-14
- Subjects:
- antibiotic -- cytotoxicity -- genotoxicity -- Mycobacterium tuberculosis -- TB -- triazenide salts
Drugs -- Design -- Periodicals
Pharmaceutical chemistry -- Periodicals
Biochemistry -- Periodicals
615.19005 - Journal URLs:
- http://gateway.ovid.com/ovidweb.cgi?T=JS&MODE=ovid&NEWS=n&PAGE=toc&D=ovft&AN=01253034-000000000-00000 ↗
http://onlinelibrary.wiley.com/journal/10.1111/(ISSN)1747-0285 ↗
http://www.blackwell-synergy.com/loi/jpp ↗
http://onlinelibrary.wiley.com/ ↗ - DOI:
- 10.1111/cbdd.13087 ↗
- Languages:
- English
- ISSNs:
- 1747-0277
- Deposit Type:
- Legaldeposit
- View Content:
- Available online (eLD content is only available in our Reading Rooms) ↗
- Physical Locations:
- British Library DSC - 3139.120000
British Library DSC - BLDSS-3PM
British Library STI - ELD Digital store - Ingest File:
- 8975.xml